Akoya Biosciences Inc (NAS:AKYA)
$ 2.5 -0.05 (-1.96%) Market Cap: 126.39 Mil Enterprise Value: 165.50 Mil PE Ratio: 0 PB Ratio: 9.11 GF Score: 46/100

Q4 2022 Akoya Biosciences Inc Earnings Call Transcript

Mar 06, 2023 / 10:00PM GMT
Release Date Price: $11.15 (-5.11%)
Operator

Thank you for standing by, and welcome to the Akoya Biosciences Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded. I will now turn the conference over to your host, Mr. Priyam Shah, Head of Investor Relations. Please go ahead, sir.

Priyam Shah
Akoya Biosciences, Inc. - Senior Director of Business Development & IR Strategy

Thank you, operator, and thank you to everyone who is joining us today on this call. I'm Priyam Shah, I'm Head of Investor Relations at Akoya Biosciences. On the call today we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer.

Earlier today Akoya released financial results for the fourth quarter ended December 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot